[Diagnostic utility of AxSYM anti-cyclic Citrullinated peptide antibody assay].
暂无分享,去创建一个
W. Chung | K. Woo | Jin-Yeong Han | Sung Won Lee | K. Kim | Jeong-Man Kim | Kyung-Eun Kim | S. W. Lee
[1] S. Cho,et al. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis]. , 2008, The Korean journal of laboratory medicine.
[2] K. Liao,et al. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis , 2008, Annals of the rheumatic diseases.
[3] M. Malaise,et al. Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[4] R. Westhovens,et al. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. , 2007, Clinical chemistry.
[5] W. Maksymowych,et al. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. , 2006, The Journal of rheumatology.
[6] M. Dougados,et al. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review , 2005, Annals of the rheumatic diseases.
[7] B. Dijkmans,et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.
[8] R. Sanmartí,et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? , 2003, Rheumatology.
[9] M. Newkirk. Rheumatoid factors: host resistance or autoimmunity? , 2002, Clinical immunology.
[10] J. Smolen,et al. Autoantibodies in rheumatoid arthritis and their clinical significance , 2002, Arthritis research.
[11] M. V. van Boekel,et al. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value , 2001, Arthritis research.
[12] S. van der Linden,et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis , 1997, The Lancet.
[13] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[14] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[15] R. Dhawan. Associations of Erosive Arthritis with Anti-Cyclic Citrullinated Peptide Antibodies and MHC Class II Alleles in Systemic Lupus Erythematosus , 2009 .
[16] M. van Oosterhout,et al. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[17] D. Kimpel. Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis , 2008 .
[18] J. Hazes,et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.
[19] J J Anderson,et al. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. , 2000, Arthritis and rheumatism.